0.55Open0.55Pre Close0 Volume79 Open Interest1.50Strike Price0.00Turnover0.00%IV-10.85%PremiumDec 20, 2024Expiry Date0.64Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.43Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Ocugen Stock Discussion
Grabbed a few at .88. It usually hovers around $1-2, a little upside
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
No comment yet